1. Home
  2. DGICA vs XERS Comparison

DGICA vs XERS Comparison

Compare DGICA & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGICA
  • XERS
  • Stock Information
  • Founded
  • DGICA 1986
  • XERS 2005
  • Country
  • DGICA United States
  • XERS United States
  • Employees
  • DGICA N/A
  • XERS N/A
  • Industry
  • DGICA Property-Casualty Insurers
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGICA Finance
  • XERS Health Care
  • Exchange
  • DGICA Nasdaq
  • XERS Nasdaq
  • Market Cap
  • DGICA 683.3M
  • XERS 752.7M
  • IPO Year
  • DGICA N/A
  • XERS 2018
  • Fundamental
  • Price
  • DGICA $16.75
  • XERS $5.38
  • Analyst Decision
  • DGICA Hold
  • XERS Strong Buy
  • Analyst Count
  • DGICA 1
  • XERS 6
  • Target Price
  • DGICA $18.00
  • XERS $6.25
  • AVG Volume (30 Days)
  • DGICA 146.4K
  • XERS 1.7M
  • Earning Date
  • DGICA 07-24-2025
  • XERS 08-07-2025
  • Dividend Yield
  • DGICA 4.26%
  • XERS N/A
  • EPS Growth
  • DGICA 965.80
  • XERS N/A
  • EPS
  • DGICA 2.34
  • XERS N/A
  • Revenue
  • DGICA $993,645,050.00
  • XERS $222,551,000.00
  • Revenue This Year
  • DGICA $3.27
  • XERS $35.31
  • Revenue Next Year
  • DGICA $5.19
  • XERS $19.65
  • P/E Ratio
  • DGICA $7.32
  • XERS N/A
  • Revenue Growth
  • DGICA 3.36
  • XERS 29.88
  • 52 Week Low
  • DGICA $13.35
  • XERS $2.10
  • 52 Week High
  • DGICA $21.12
  • XERS $6.07
  • Technical
  • Relative Strength Index (RSI)
  • DGICA 28.67
  • XERS 62.75
  • Support Level
  • DGICA $18.17
  • XERS $4.94
  • Resistance Level
  • DGICA $17.96
  • XERS $5.22
  • Average True Range (ATR)
  • DGICA 0.48
  • XERS 0.22
  • MACD
  • DGICA -0.12
  • XERS -0.01
  • Stochastic Oscillator
  • DGICA 10.85
  • XERS 86.44

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: